FindMyKOL

Michael Weller, MD

Enriched profile

Associate Staff in the Department of Radiation Oncology at Hillcrest Hospital · Hillcrest Hospital (Cleveland Clinic)

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Cleveland, OH · Midwest · United StatesSpecialtyRadiation OncologyFocusNeuro-Oncology / Glioma+7
ActivityNone indexedFindMyKOL type: RegionalLatest publicationNone indexedOnline presenceNone verifiedPaymentsNone reportedNIH fundingNone on fileWhy? →

Michael Weller is Associate Staff in the Department of Radiation Oncology at Hillcrest Hospital at Hillcrest Hospital (Cleveland Clinic). ClinicalTrials.gov lists 14 registered studies with this person as an investigator.

Data verified 9 Nov 2026

Overview

Updated 17 Nov 2026

Michael Weller, M.D., is Associate Staff in the Department of Radiation Oncology at Hillcrest Hospital. It also documents an investigator role on 14 registered clinical trials.

  • Top research focus: Neuro-Oncology / Glioma
  • 14 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Neuro-Oncology / Glioma9 trialsAstrocytoma3 trialsGlioma3 trialsOligodendroglioma2 trialsBrain Neoplasms1 trialEpendymoma1 trialEpilepsy1 trialHemangioblastoma1 trialHemangiopericytoma1 trialHydrocephalus1 trialHydrocephalus, Normal Pressure1 trialLymphoma1 trialMelanoma1 trialNeoplasms, Germ Cell and Embryonal1 trialLung Cancer (NSCLC/SCLC)1 trialPain1 trialParesis1 trialPinealoma1 trialSmall Cell Lung Carcinoma1 trial

Research focus

OpenAlex concept fingerprint
Neuro-Oncology / GliomaAstrocytomaGliomaLung Cancer (NSCLC/SCLC)LymphomaMelanomaOligodendrogliomaSmall Cell Lung Carcinoma

Works with

trial sponsors and companies reporting payments
European Organisation for Research and Treatment of Cancer - EORTCClinical trials3Industry payments—University of ZurichClinical trials3Industry payments—PIQUR Therapeutics AGClinical trials2Industry payments—University Hospital TuebingenClinical trials2Industry payments—ETOP IBCSG Partners FoundationClinical trials1Industry payments—Heidelberg UniversityClinical trials1Industry payments—Neuro-Oncology Working Group of the German Cancer SocietyClinical trials1Industry payments—Prof. Dr. Wolfgang WickClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
14clinical trials

Investigator role on registered studies.

View trials ↓
0companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 9 Nov 2026

Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

No payments involving this person were reported to CMS in program years 2021–2024. Why? →

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Genitourinary & hormones

    100%
    alpha-Adrenergic Blocker100%
    Tamsulosin Hcl100%
    Part D≥19 patients
Where care is delivered (Part B)14.2% facility · 85.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Background & recognition

Updated 9 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.